Amynas develops biodegradable drug-eluting nanofiber envelopes for surgical implants to prevent infections and promote healthy tissue growth.
Amynas is a medical device company whose lead candidate is a bioresorbable pouch of electrospun nanofibers designed to promote healthy tissue growth around implants and counteract infections. The product is described as soft, easy to use, requiring no preparation, and designed to prevent hospital-acquired infections.
LODE DEBRABANDERE - CO-FOUNDER CEO
STEFAN VERHEYE - CO-FOUNDER